Digital Content 
NEWS #PharmaBuzz
09 Sep 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/oncxerna-subject-navicixizumab-trial/
08 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/08/2512403/0/en/OncXerna-Therapeutics-Doses-First-Patient-in-Phase-2-Trial-Evaluating-Navicixizumab-Alone-or-in-Combination-with-Chemotherapy-in-Patients-with-Select-Advanced-Solid-Tumors.html
23 Oct 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/10/23/2319430/0/en/OncXerna-Therapeutics-Announces-New-Biomarker-Data-from-Retrospective-Analysis-of-Results-from-Phase-1b-Ovarian-Cancer-Trial-of-Navicixizumab-Plus-Paclitaxel-at-the-ESGO-2021-Congr.html
16 Jun 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/oncologie-announces-key-updates-and-planned-activities-for-its-clinical-programs-and-rna-based-biomarker-platform-301075224.html
12 Feb 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/02/12/1983782/0/en/Mereo-BioPharma-Announces-Update-on-Distribution-Related-to-Contingent-Value-Rights-Following-Recent-Oncologie-Licensing-Agreement-for-Navicixizumab.html
14 Jan 2020
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2020-01-14/oncologie-receives-exclusive-navicixizumab-license/
LOOKING FOR A SUPPLIER?
Share